Related references
Note: Only part of the references are listed.Phosphodiesterase 1C integrates store-operated calcium entry and cAMP signaling in leading-edge protrusions of migrating human arterial myocytes
Paulina Brzezinska et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2021)
Acute Hemodynamic Effects and Tolerability of Phosphodiesterase-1 Inhibition With ITI-214 in Human Systolic Heart Failure
Nisha A. Gilotra et al.
CIRCULATION-HEART FAILURE (2021)
Selective Phosphodiesterase 1 Inhibition Ameliorates Vascular Function, Reduces Inflammatory Response, and Lowers Blood Pressure in Aging Animals
Keivan Golshiri et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2021)
Vascular Ageing Features Caused by Selective DNA Damage in Smooth Muscle Cell
Ehsan Ataei Ataabadi et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2021)
Microvascular Sex- and Age- Dependent Phosphodiesterase Expression
Jianjie Wang et al.
FRONTIERS IN AGING (2021)
Long-lasting blood pressure lowering effects of nitrite are NO-independent and mediated by hydrogen peroxide, persulfides, and oxidation of protein kinase G1 alpha redox signalling
Martin Feelisch et al.
CARDIOVASCULAR RESEARCH (2020)
Established and emerging therapeutic uses of PDE type 5 inhibitors in cardiovascular disease
Nikolaos Tzoumas et al.
BRITISH JOURNAL OF PHARMACOLOGY (2020)
Chronic Sildenafil Treatment Improves Vasomotor Function in a Mouse Model of Accelerated Aging
Keivan Golshiri et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Nitric Oxide-cGMP Signaling in Hypertension Current and Future Options for Pharmacotherapy
Ehsan Ataei Ataabadi et al.
HYPERTENSION (2020)
Selective Phosphodiesterase 1 Inhibitor BTTQ Reduces Blood Pressure in Spontaneously Hypertensive and Dahl Salt Sensitive Rats: Role of Peripheral Vasodilation
Asim B. Dey et al.
FRONTIERS IN PHYSIOLOGY (2020)
Smooth muscle-specific Gsa deletion exaggerates angiotensin II-induced abdominal aortic aneurysm formation in mice in vivo
Xiaoteng Qin et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2019)
Calcium in Vascular Smooth Muscle Cell Elasticity and Adhesion: Novel Insights Into the Mechanism of Action
Yi Zhu et al.
FRONTIERS IN PHYSIOLOGY (2019)
An EPAC1/PDE1C-Signaling Axis Regulates Formation of Leading-Edge Protrusion in Polarized Human Arterial Vascular Smooth Muscle Cells
Paulina Brzezinska et al.
CELLS (2019)
PDE3 Inhibitors Repurposed as Treatments for Age-Related Cognitive Impairment
Shuichi Yanai et al.
MOLECULAR NEUROBIOLOGY (2019)
PDE5 inhibitors - pharmacology and clinical applications 20 years after sildenafil discovery
K-E Andersson
BRITISH JOURNAL OF PHARMACOLOGY (2018)
Multiprotein Complex With TRPC (Transient Receptor Potential-Canonical) Channel, PDE1C (Phosphodiesterase 1C), and A2R (Adenosine A2 Receptor) Plays a Critical Role in Regulating Cardiomyocyte cAMP and Survival
Yishuai Zhang et al.
CIRCULATION (2018)
Acute Enhancement of Cardiac Function by Phosphodiesterase Type 1 Inhibition: Translational Study in the Dog and Rabbit
Toru Hashimoto et al.
CIRCULATION (2018)
Prevention of PKG-1α Oxidation Suppresses Antihypertrophic/Antifibrotic Effects From PDE5 Inhibition but not sGC Stimulation
Taishi Nakamura et al.
CIRCULATION-HEART FAILURE (2018)
Discovery of Potent and Selective Periphery-Restricted Quinazoline Inhibitors of the Cyclic Nucleotide Phosphodiesterase PDE1
John M. Humphrey et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Phosphodiesterase-4 Inhibitors for the Treatment of Inflammatory Diseases
Heng Li et al.
FRONTIERS IN PHARMACOLOGY (2018)
Novel selective PDE type 1 inhibitors cause vasodilatation and lower blood pressure in rats
Morten Laursen et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
Modulation of Polycystic Kidney Disease Severity by Phosphodiesterase 1 and 3 Subfamilies
Hong Ye et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Chronic senolytic treatment alleviates established vasomotor dysfunction in aged or atherosclerotic mice
Carolyn M. Roos et al.
AGING CELL (2016)
Old dog, new tricks: novel cardiac targets and stress regulation by protein kinase G
Peter P. Rainer et al.
CARDIOVASCULAR RESEARCH (2016)
Age-Associated Sirtuin 1 Reduction in Vascular Smooth Muscle Links Vascular Senescence and Inflammation to Abdominal Aortic Aneurysm
Hou-Zao Chen et al.
CIRCULATION RESEARCH (2016)
Cyclic AMP Sensor EPAC Proteins and Their Role in Cardiovascular Function and Disease
Frank Lezoualc'h et al.
CIRCULATION RESEARCH (2016)
Discovery of Potent and Selective Inhibitors of Phosphodiesterase 1 for the Treatment of Cognitive Impairment Associated with Neurodegenerative and Neuropsychiatric Diseases
Peng Li et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Naturally occurring p16Ink4a-positive cells shorten healthy lifespan
Darren J. Baker et al.
NATURE (2016)
Preclinical profile of ITI-214, an inhibitor of phosphodiesterase 1, for enhancement of memory performance in rats
Gretchen L. Snyder et al.
PSYCHOPHARMACOLOGY (2016)
DNA Damage: A Main Determinant of Vascular Aging
Paula K. Bautista-Nino et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Role of cAMP-Phosphodiesterase 1C Signaling in Regulating Growth Factor Receptor Stability, Vascular Smooth Muscle Cell Growth, Migration, and Neointimal Hyperplasia
Yujun Cai et al.
CIRCULATION RESEARCH (2015)
Phosphodiesterase 1 regulation is a key mechanism in vascular aging
Paula K. Bautista Nino et al.
CLINICAL SCIENCE (2015)
Cyclic Nucleotide Phosphodiesterases: important signaling modulators and therapeutic targets
F. Ahmad et al.
ORAL DISEASES (2015)
Gene-centric Meta-analysis in 87,736 Individuals of European Ancestry Identifies Multiple Blood-Pressure-Related Loci
Vinicius Tragante et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2014)
Advances in targeting cyclic nucleotide phosphodiesterases
Donald H. Maurice et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Small-molecule phosphodiesterase probes: discovery of potent and selective CNS-penetrable quinazoline inhibitors of PDE1
John M. Humphrey et al.
MEDCHEMCOMM (2014)
Recurrent Gain-of-Function Mutation in PRKG1 Causes Thoracic Aortic Aneurysms and Acute Aortic Dissections
Dong-Chuan Guo et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2013)
Inhibitory Effects of Vinpocetine on the Progression of Atherosclerosis Are Mediated by Akt/NF-κB Dependent Mechanisms in apoE-/- Mice
Jianhui Zhuang et al.
PLOS ONE (2013)
Increase in Cellular Cyclic AMP Concentrations Reverses the Profibrogenic Phenotype of Cardiac Myofibroblasts: A Novel Therapeutic Approach for Cardiac Fibrosis
David Lu et al.
MOLECULAR PHARMACOLOGY (2013)
Nitroglycerin Fails to Lower Blood Pressure in Redox-Dead Cys42Ser PKG1α Knock-In Mouse
Olena Rudyk et al.
CIRCULATION (2012)
Nucleotide Excision DNA Repair Is Associated With Age-Related Vascular Dysfunction
Matej Durik et al.
CIRCULATION (2012)
cGMP-Dependent Activation of Protein Kinase G Precludes Disulfide Activation Implications for Blood Pressure Control
Joseph Robert Burgoyne et al.
HYPERTENSION (2012)
PDEs create local domains of cAMP signaling
Delphine Mika et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2012)
Cyclic Nucleotide Phosphodiesterase 1 Regulates Lysosome-Dependent Type I Collagen Protein Degradation in Vascular Smooth Muscle Cells
Yujun Cai et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Cyclic nucleotide phosphodiesterase 1A: a key regulator of cardiac fibroblast activation and extracellular matrix remodeling in the heart
Clint L. Miller et al.
BASIC RESEARCH IN CARDIOLOGY (2011)
Decreased cGMP Level Contributes to Increased Contraction in Arteries From Hypertensive Rats Role of Phosphodiesterase 1
Fernanda R. Giachini et al.
HYPERTENSION (2011)
Mammalian Cyclic Nucleotide Phosphodiesterases: Molecular Mechanisms and Physiological Functions
Sharron H. Francis et al.
PHYSIOLOGICAL REVIEWS (2011)
Intrinsic sex-specific differences in microvascular endothelial cell phosphodiesterases
Jianjie Wang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2010)
Vinpocetine inhibits NF-κB-dependent inflammation via an IKK-dependent but PDE-independent mechanism
Kye-Im Jeon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Role of Ca2+/Calmodulin-Stimulated Cyclic Nucleotide Phosphodiesterase 1 in Mediating Cardiomyocyte Hypertrophy
Clint L. Miller et al.
CIRCULATION RESEARCH (2009)
Protein Kinase G Modulates Human Myocardial Passive Stiffness by Phosphorylation of the Titin Springs
Martina Krueger et al.
CIRCULATION RESEARCH (2009)
PDE4 inhibitors: a review of current developments (2005-2009)
Lluis Pages et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2009)
Muscarinic receptor M1 and phosphodiesterase 1 are key determinants in pulmonary vascular dysfunction following perinatal hypoxia in mice
Anne-Christine Peyter et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2008)
Atrial natriuretic peptide inhibits transforming growth factor β-induced Smad signaling and myofibroblast transformation in mouse cardiac fibroblasts
Peng Li et al.
CIRCULATION RESEARCH (2008)
Cyclic nucleotide phosphodiesterase PDE1C1 in human cardiac myocytes
Fabrice Vandeput et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Characterization of inhibitors of phosphodiesterase 1C on a human cellular system
Torsten R. Dunkern et al.
FEBS JOURNAL (2007)
Phosphodiesterase 1 upregulation in pulmonary arterial hypertension target for reverse-remodeling therapy
Ralph Theo Schermuly et al.
CIRCULATION (2007)
Overview of PDEs and their regulation
Kenji Omori et al.
CIRCULATION RESEARCH (2007)
Role of nuclear Ca2+/calmodulin-stimulated phosphodiesterase 1A in vascular smooth muscle cell growth and survival
DJ Nagel et al.
CIRCULATION RESEARCH (2006)
Isoforms of cyclic nucleotide phosphodiesterase PDE3 and their contribution to cAMP hydrolytic activity in subcellular fractions of human myocardium
R Hambleton et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Phosphodiesterase 5 and effects of sildenafil on cerebral arteries of man and guinea pig
C Kruuse et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2005)
Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy
E Takimoto et al.
NATURE MEDICINE (2005)
PDE5 is converted to an activated state upon cGMP binding to the GAF A domain
SD Rybalkin et al.
EMBO JOURNAL (2003)
Characterisation of cyclic nucleotide phosphodiesterase isoforms in the media layer of the main pulmonary artery
O Pauvert et al.
BIOCHEMICAL PHARMACOLOGY (2002)
Cyclic nucleotide phosphodiesterase 1C promotes human arterial smooth muscle cell proliferation
SD Rybalkin et al.
CIRCULATION RESEARCH (2002)
Upregulation of phosphodiesterase 1A1 expression is associated with the development of nitrate tolerance
D Kim et al.
CIRCULATION (2001)
Cyclic nucleotide hydrolysis in bovine aortic endothelial cells in culture: Differential regulation in cobblestone and spindle phenotypes
T Keravis et al.
JOURNAL OF VASCULAR RESEARCH (2000)
Share Paper
